Abbott Heart Pump Manufacturing-Defect Lawsuit Proceeds

Sept. 27, 2021, 3:11 PM UTC

Abbott Laboratories must face manufacturing defect claims in a suit alleging a recalled heart pump malfunctioned and caused complications that led to a patient’s removal from the heart transplant list, a Louisiana federal court said.

But William McKenzie’s claims alleging the company didn’t adequately train doctors, didn’t timely report complications, and breached an express warranty that its Heartmate 3 was superior to other devices were dismissed, for now.

McKenzie received a Heartmate 3 on Sept. 5, 2017, while waiting for a transplant. The device reroutes and pumps blood from the left ventricle into the ascending aorta.

Abbott recalled the Heartmate ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.